UNSPSC 51281814: Amrubicin hydrochloride

This classification denotes an anthracycline antibiotic with the molecular formula C25H25NO9.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EUL6MP8FZW, chemically known as 5,12-naphthacenedione, 9-acetyl-7-((2-deoxy-beta-d-erythro-pentopyranosyl)oxy)-7,8,9,10-tetrahydro-6,11-dihydroxy-, hydrochloride, (7s,9s)- but more generally known as amrubicin hydrochloride, which bears US NIH Compound Identifier 114897.

UNSPSC 51281814 Amrubicin hydrochloride is a Commodity code for a specific injectable cancer therapeutic, yet recent state and local procurement activity under this code shows minimal relevant purchasing. The source record identifies one completed pharmaceutical warehouse piggyback contract awarded by the Illinois Department of Public Health to Chartwell Rx LLC on August 28, 2026, but that contract supplies Doxycycline Hyclate and Ciprofloxacin Hydrochloride—neither of which is amrubicin hydrochloride. A second record, a Seminole County, Florida IFB for Naloxone and drug deactivation systems, is equally unrelated to the code's nominal scope. State and local governments do procure pharmaceuticals through cooperative purchasing vehicles such as MMCAP Infuse and through traditional IFB processes, but the tagged opportunities do not reflect actual purchasing under this specific commodity code.

The source shows no open or recent solicitations for amrubicin hydrochloride itself from state or local issuers. The only completed award nominally associated with this code—the Illinois Department of Public Health piggyback contract for $2,999,999.11 over 12 months with renewal options through year 3, awarded August 28, 2026—supplies different drugs entirely. State pharmacy benefit managers and health departments may purchase specialty oncology drugs through national cooperative agreements or state formulary channels, but those transactions are not surfacing here. Practitioners should treat this code as showing little active state and local procurement opportunity at present and verify any opportunities that appear under this code against the actual pharmaceutical products being requested, as tagging mismatches are evident in the available records.